{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:02:11Z","timestamp":1795194131865,"version":"4.10.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The levels of serum D-dimer (D-D) in children with\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (MPP) were assessed to explore the clinical significance of D-D levels in refractory MPP (RMPP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      A total of 430 patients with MPP were enrolled between January 2015 and December 2015 and divided into a general MPP (GMPP) group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009306) and a RMPP group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009124). Clinical data, D-D level, white blood cell (WBC) count, proportion of neutrophils (N%), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), alanine transaminase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) were compared between the two groups. Multivariate logistic regression was performed to identify independent predictors of RMPP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      (1) Hospitalization time, preadmission fever duration, total fever duration, WBC, N %, CRP, LDH, ESR, ALT, AST, and D-D were significantly higher in the RMPP group than those in the GMPP group (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). (2) Correlation analysis showed that D-D was positively correlated with WBC, CRP, ESR, and LDH, and could be used to jointly evaluate the severity of the disease. (3) Multivariate logistic regression analysis identified preadmission fever duration, CRP, LDH and DD as independent risk factors for RMPP (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090. 05). D-D had the highest predictive power for RMPP (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). The D-D level also had a good ability to predict pleural effusion and liver injury (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum D-D levels were significantly increased in patients with RMPP, indicating that excessive inflammatory response and vascular endothelial injury with prolonged duration existed in this patient population. Increased levels of serum D-D may be used as an early predictor of RMPP and the occurrence of complications. Our findings provide a theoretical basis for the early diagnosis of RMPP, early intervention and excessive inflammatory response in the pathogenesis of mycoplasma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05700-5","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T15:05:26Z","timestamp":1609945526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia"],"prefix":"10.1186","volume":"21","author":[{"given":"Xia","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0095-3816","authenticated-orcid":false,"given":"Heng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"3","key":"5700_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/jmv.24963","volume":"90","author":"H Oumei","year":"2018","unstructured":"Oumei H, Xuefeng W, Jianping L, et al. Etiology of community-acquired pneumonia in 1500 hospitalized children. J Med Virol. 2018;90(3):421\u20138.","journal-title":"J Med Virol"},{"key":"5700_CR2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000839","volume":"147","author":"LW Gao","year":"2019","unstructured":"Gao LW, Yin J, Hu YH, et al. The epidemiology of paediatric mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol Infect. 2019;147:e192.","journal-title":"Epidemiol Infect"},{"issue":"5","key":"5700_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/INF.0000000000001471","volume":"36","author":"L Ravelomanana","year":"2017","unstructured":"Ravelomanana L, Bouazza N, Rakotomahefa M, et al. Prevalence of mycoplasma pneumoniae infection in Malagasy children. Pediatr Infect Dis J. 2017;36(5):467\u201371.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"5700_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12879-020-4774-9","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu J, He R, Wu R, et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children\u2019s hospital. BMC Infect Dis. 2020;20(1):51.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5700_CR5","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1038\/s41598-017-13292-5","volume":"7","author":"M Yang","year":"2017","unstructured":"Yang M, Meng F, Wang K, et al. Interleukin 17A as a good predictor of the severity of mycoplasma pneumoniae pneumonia in children. Sci Rep. 2017;7(1):12934.","journal-title":"Sci Rep"},{"issue":"5","key":"5700_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156465","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhou Y, Li S, et al. The clinical characteristics and predictors of refractory mycoplasma pneumoniae pneumonia in children. PLoS One. 2016;11(5):e0156465.","journal-title":"PLoS One"},{"issue":"10","key":"5700_CR7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4187\/respcare.03920","volume":"60","author":"A Lu","year":"2015","unstructured":"Lu A, Wang C, Zhang X, et al. Lactate dehydrogenase as a biomarker for prediction of refractory mycoplasma pneumoniae pneumonia in children. Respir Care. 2015;60(10):1469\u201375.","journal-title":"Respir Care"},{"issue":"1","key":"5700_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12931-019-1152-5","volume":"20","author":"YJ Choi","year":"2019","unstructured":"Choi YJ, Jeon JH, Oh JW. Critical combination of initial markers for predicting refractory mycoplasma pneumoniae pneumonia in children: a case control study. Respir Res. 2019;20(1):193.","journal-title":"Respir Res"},{"issue":"1","key":"5700_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10020-019-0105-2","volume":"25","author":"G Li","year":"2019","unstructured":"Li G, Fan L, Wang Y, Huang L, et al. High co-expression of TNF-\u03b1 and CARDS toxin is a good predictor for refractory mycoplasma pneumoniae pneumonia. Mol Med. 2019;25(1):38.","journal-title":"Mol Med"},{"issue":"50","key":"5700_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009364","volume":"96","author":"L Wang","year":"2017","unstructured":"Wang L, Lu S, Feng Z, et al. The early examination of combined serum and imaging data under flexible fiberoptic bronchoscopy as a novel predictor for refractory mycoplasma pneumoniae pneumonia diagnosis. Medicine. 2017;96(50):e9364.","journal-title":"Medicine."},{"issue":"2","key":"5700_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/ijms18020388","volume":"18","author":"KY Lee","year":"2017","unstructured":"Lee KY. Pneumonia, acute respiratory distress syndrome, and early immune-modulator therapy. Int J Mol Sci. 2017;18(2):388.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5700_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, et al. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747\u2013809.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"5700_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12519-017-0014-9","volume":"13","author":"LS Shan","year":"2017","unstructured":"Shan LS, Liu X, Kang XY, et al. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory mycoplasma Pneumoniae pneumonia in children. World J Pediatr. 2017;13(4):321\u20137.","journal-title":"World J Pediatr"},{"issue":"2","key":"5700_CR14","first-page":"148","volume":"63","author":"Q Xu","year":"2017","unstructured":"Xu Q, Zhang L, Hao C, et al. Prediction of bronchial mucus plugs formation in patients with refractory mycoplasma Pneumoniae pneumonia. J Trop Pediatr. 2017;63(2):148\u201354.","journal-title":"J Trop Pediatr"},{"key":"5700_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12887-015-0357-0","volume":"15","author":"B Kalicki","year":"2015","unstructured":"Kalicki B, Sadecka M, Wawrzyniak A, et al. Absence of inferior vena cava in 14-year old boy associated with deep venous thrombosis and positive Mycoplasma pneumoniae serum antibodies--a case report. BMC Pediatr. 2015;15:40.","journal-title":"BMC Pediatr"},{"issue":"6","key":"5700_CR16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","volume":"18","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324\u20139.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"5700_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/jth.13630","volume":"15","author":"N Van Es","year":"2017","unstructured":"Van Es N, Kraaijpoel N, Klok FA, et al. The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis. J Thromb Haemost. 2017;15(4):678\u201384.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5700_CR18","first-page":"229","volume":"22","author":"X Yin","year":"2018","unstructured":"Yin X, Liu P, Liu BY, et al. Preventive effects of low molecular weight heparin on formation of deep vein thrombosis by reducing D dimer values in patients undergoing spinal surgery. Eur Rev Med Pharmacol Sci. 2018;22(1):229\u201337.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5700_CR19","doi-asserted-by":"crossref","unstructured":"Ge YL, Liu CH, Wang N, et al. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival. Clin Lab. 2019;65(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/30775898\/.","DOI":"10.7754\/Clin.Lab.2018.180720"},{"issue":"6","key":"5700_CR20","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1177\/0300060517709613","volume":"45","author":"T Li","year":"2017","unstructured":"Li T, Yu H, Hou W, et al. Evaluation of variation in coagulation among children with Mycoplasma pneumoniae pneumonia: a case-control study. J Int Med Res. 2017;45(6):2110\u20138.","journal-title":"J Int Med Res"},{"issue":"6","key":"5700_CR21","first-page":"5025","volume":"16","author":"X Jin","year":"2018","unstructured":"Jin X, Zhu Y, Zhang Y, et al. Assessment of levels of D-dimer and interferon-\u03b3 in pediatric patients with Mycoplasma pneumoniae pneumonia and its clinical implication. Exp Ther Med. 2018;16(6):5025\u201330.","journal-title":"Exp Ther Med"},{"issue":"12","key":"5700_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023719","volume":"8","author":"L Huang","year":"2018","unstructured":"Huang L, Huang X, Jiang W, et al. Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: a prospective cohort study. BMJ Open. 2018;8(12):e023719.","journal-title":"BMJ Open"},{"issue":"2","key":"5700_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3345\/kjp.2012.55.2.42","volume":"55","author":"YS Youn","year":"2012","unstructured":"Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012;55(2):42\u20137.","journal-title":"Korean J Pediatr"},{"issue":"5","key":"5700_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/jcm8050726","volume":"8","author":"EA Yang","year":"2019","unstructured":"Yang EA, Kang HM, Rhim JW, et al. Early corticosteroid therapy for Mycoplasma pneumoniae pneumonia irrespective of used antibiotics in children. J Clin Med. 2019;8(5):726.","journal-title":"J Clin Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05700-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05700-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05700-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T18:10:55Z","timestamp":1610215855000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05700-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5700"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05700-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-42480\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42480\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42480\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42480\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Children\u2019s Hospital of Nanjing Medical University (Grant NO.202008090\u20131). Individual informed consent was waived by the ethics committee listed above because this study used currently existing sample collected during the course of routine medical care and did not pose any additional risks to the patients. All patient data were anonymized prior to the analysis. Any administrative permissions and\/or licenses were acquired by the ethics committee of the Children\u2019s Hospital of Nanjing Medical University to access the data used in our research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}